Skip to content
No picture yet

Orgovyx 120 mg – DIN 02542137

Orgovyx is Relugolix 120 mg (tablet), sold in Canada. It is used for prostate cancer. It is supplied by Knight Therapeutics Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Relugolix 120 mg

Brand
Orgovyx
Strength
120 mg
Used for
Prostate cancer
Form
Tablet
Manufacturer
Knight Therapeutics Inc
Drug class
Gonadotropin releasing hormone receptor antagonist
Sold in
Canada
DIN
02542137

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Relugolix pills and guides

What is Relugolix used for?

Relugolix is used for prostate cancer.

Medicine type
Gonadotropin releasing hormone receptor antagonist
Official uses from the US prescribing label

ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.

From the FDA-approved label on DailyMed (published Nov 17, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02542137.
  • It names Orgovyx, Relugolix 120 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Orgovyx by Knight Therapeutics Inc..

In Canada: prescription only.

Ingredients

Active: Relugolix

Other Relugolix pills